Screener
Anika Therapeutics ANIK Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Anika Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001171843-26-005012
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | $32,610 | $28,219 | $62,222 | $54,387 |
| Cost of product revenue | 11,366 | 13,856 | 21,981 | 25,343 |
| Gross Profit | 21,244 | 14,363 | 40,241 | 29,044 |
| Operating expenses: | ||||
| Research & development | 7,341 | 6,313 | 14,054 | 12,372 |
| Selling, general & administrative | 10,949 | 12,230 | 28,721 | 25,136 |
| Total operating expenses | 18,290 | 18,543 | 42,775 | 37,508 |
| Income (loss) from operations | 2,954 | (4,180) | (2,534) | (8,464) |
ITEM 1. FINANCIAL STATEMENTS[ Item 1. Condensed Consolidated Financial Statements (unaudited): ](#)
FAQ
- What is Anika Therapeutics's total revenue?
- Anika Therapeutics (ANIK) reported total revenue of $32.61M in Q2 2026.
- How has Anika Therapeutics's total revenue changed year-over-year?
- Anika Therapeutics's total revenue increased by 15.6% year-over-year, from $28.22M to $32.61M.
- What is the long-term trend for Anika Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Anika Therapeutics's total revenue has grown at a -6.5% compound annual growth rate (CAGR), from $147.79M to $112.82M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Anika Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude